TrialFrontiers in immunology2021

miR-18a-3p and Its Target Protein HuR May Regulate Myogenic Differentiation in Immune-Mediated Necrotizing Myopathy.

Lifang Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.